PRECISION PHENOTYPE

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark PRECISION PHENOTYPE was filed as Word mark on 05/25/2021 at the World Intellectual Property Organization.

Trademark Details Last update: July 6, 2023

Trademark form Word mark
File reference 1641756
Countries Australia Brazil Canada China em United Kingdom Israel India Japan South Korea Mexico Russia
Base trademark US No. 90356587, December 3, 2020
Application date May 25, 2021
Expiration date May 25, 2031

Trademark owner

8000 Marina Blvd, Suite 700
Brisbane CA 94005
US

Trademark representatives

PO Box 1022 Minneapolis MN 55440-1022 US

goods and services

05 Pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders
42 Research and development of pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders; scientific research, namely, analyzing genetic, genomic, biological and clinical data; scientific research, namely, analyzing genetic, genomic, biological and clinical data for research and development relating to the treatment of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders via targeted drug therapies
44 Medical analysis services relating to the treatment of patients, namely, analyzing genetic, genomic, biological and clinical data; medical analysis services relating to the treatment of patients, namely, analyzing genetic, genomic, biological and clinical data for the development and treatment of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders via targeted drug therapies

Trademark history

Date Document number Area Entry
June 29, 2023 2023/26 Gaz JP RAW: Rule 18ter(2)(i) GP following a provisional refusal
May 17, 2023 2023/20 Gaz AU Rejection
May 16, 2023 2023/20 Gaz CA Rejection
February 22, 2023 2023/9 Gaz KR Rejection
December 23, 2022 2022/52 Gaz RU Rejection
November 3, 2022 2022/44 Gaz JP Rejection
October 31, 2022 2022/44 Gaz MX Rejection
September 28, 2022 2022/39 Gaz BR Rejection
August 18, 2022 2022/33 Gaz CN Rejection
June 22, 2022 2022/25 Gaz EM Rejection
June 20, 2022 2022/26 Gaz IL Rejection
May 2, 2022 2022/18 Gaz RU Rejection
April 27, 2022 2022/17 Gaz GB Rejection
February 21, 2022 2022/9 Gaz IN Rejection
February 9, 2022 2022/7 Gaz AU Rejection
May 25, 2021 2022/3 Gaz US Registration

ID: 141641756